Teva Pharmaceuticals USA recalls Clonidine Transdermal System, USP 0.1 mg/day, 4 patches per carton, Rx only, Manufactured by: Actavis Laboratories, UT I
Recalled November 24, 2021 · FDA recall D-0235-2022 · Teva Pharmaceuticals USA
Hazard
Failed Impurities/Degradation Specifications · FDA Class III
Units
64,978 patches
Sold at
Nationwide and Puerto Rico
Description
Failed Impurities/Degradation Specifications
Product
Clonidine Transdermal System, USP 0.1 mg/day, 4 patches per carton, Rx only, Manufactured by: Actavis Laboratories, UT Inc., Salt Lake City, UT, Distributed by: Actavis Pharma, Inc., Parsippany, NJ NDC 0591-3508-04
Manufacturer(s)
Teva Pharmaceuticals USA
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →